# Optimal-strategy-and-benefit-of-non-continuous-therapy
Codes and raw data for paper titled "Optimal strategy and benefit of non-continuous therapy depend on tumor heterogeneity and aggressiveness at the time of diagnosis"
TODO: describe the data files included in the repository
Fig1andSuppFig1-2/1drugsimulationdata_paper.csv	
Fig2andSuppFig3/2drugsimulationdata_paper.csv	
Fig3andSuppFig4/Euler2drugsim.csv		
Fig3andSuppFig4/Euler1drugsim.csv		
Fig4andSuppFig5-7/tumormarkers_paper.csv
Fig4andSuppFig5-7/treatmentdata_paper.csv
Fig4andSuppFig5-7/treatmenttable_paper.csv
